Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

USA - NYSE:REX - US7616241052 - Common Stock

31.45 USD
-0.92 (-2.84%)
Last: 10/21/2025, 11:31:10 AM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to REX. REX was compared to 211 industry peers in the Oil, Gas & Consumable Fuels industry. REX has an excellent financial health rating, but there are some minor concerns on its profitability. REX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

REX had positive earnings in the past year.
REX had a positive operating cash flow in the past year.
In the past 5 years REX has always been profitable.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

REX's Return On Assets of 7.33% is fine compared to the rest of the industry. REX outperforms 76.78% of its industry peers.
REX has a Return On Equity (9.42%) which is comparable to the rest of the industry.
REX has a better Return On Invested Capital (6.87%) than 62.09% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 21.53%.
The last Return On Invested Capital (6.87%) for REX is above the 3 year average (6.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 7.33%
ROE 9.42%
ROIC 6.87%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

The Profit Margin of REX (7.91%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of REX has grown nicely.
The Operating Margin of REX (9.10%) is worse than 62.09% of its industry peers.
REX's Operating Margin has improved in the last couple of years.
The Gross Margin of REX (13.22%) is worse than 68.72% of its industry peers.
In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 9.1%
PM (TTM) 7.91%
GM 13.22%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), REX is destroying value.
The number of shares outstanding for REX has been reduced compared to 1 year ago.
REX has less shares outstanding than it did 5 years ago.
There is no outstanding debt for REX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

REX has an Altman-Z score of 7.51. This indicates that REX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.51, REX belongs to the top of the industry, outperforming 92.89% of the companies in the same industry.
REX has a debt to FCF ratio of 0.29. This is a very positive value and a sign of high solvency as it would only need 0.29 years to pay back of all of its debts.
REX has a Debt to FCF ratio of 0.29. This is amongst the best in the industry. REX outperforms 92.42% of its industry peers.
A Debt/Equity ratio of 0.01 indicates that REX is not too dependend on debt financing.
REX has a better Debt to Equity ratio (0.01) than 83.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Altman-Z 7.51
ROIC/WACC0.79
WACC8.66%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

A Current Ratio of 10.53 indicates that REX has no problem at all paying its short term obligations.
REX has a better Current ratio (10.53) than 95.73% of its industry peers.
REX has a Quick Ratio of 9.68. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 9.68, REX belongs to the top of the industry, outperforming 95.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 10.53
Quick Ratio 9.68
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for REX have decreased by -5.19% in the last year.
REX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.01% yearly.
Looking at the last year, REX shows a decrease in Revenue. The Revenue has decreased by -9.48% in the last year.
Measured over the past years, REX shows a quite strong growth in Revenue. The Revenue has been growing by 8.99% on average per year.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%-38.46%
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%7.03%

3.2 Future

Based on estimates for the next years, REX will show a decrease in Earnings Per Share. The EPS will decrease by -4.03% on average per year.
The Revenue is expected to grow by 10.00% on average over the next years. This is quite good.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 9.56, the valuation of REX can be described as very reasonable.
REX's Price/Earnings ratio is a bit cheaper when compared to the industry. REX is cheaper than 74.88% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. REX is valued rather cheaply when compared to this.
REX is valuated reasonably with a Price/Forward Earnings ratio of 10.38.
64.45% of the companies in the same industry are more expensive than REX, based on the Price/Forward Earnings ratio.
REX is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.18, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 9.56
Fwd PE 10.38
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

REX's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as REX.
Industry RankSector Rank
P/FCF 92.27
EV/EBITDA 9.12
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The decent profitability rating of REX may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.19
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (10/21/2025, 11:31:10 AM)

31.45

-0.92 (-2.84%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-25 2025-08-25/bmo
Earnings (Next)12-01 2025-12-01/bmo
Inst Owners85.18%
Inst Owner Change-0.37%
Ins Owners14.29%
Ins Owner Change3.49%
Market Cap1.04B
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.75%
Min Revenue beat(2)-4.71%
Max Revenue beat(2)-2.79%
Revenue beat(4)2
Avg Revenue beat(4)1.28%
Min Revenue beat(4)-4.71%
Max Revenue beat(4)9.23%
Revenue beat(8)3
Avg Revenue beat(8)0.51%
Revenue beat(12)6
Avg Revenue beat(12)1.89%
Revenue beat(16)9
Avg Revenue beat(16)2.48%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.56
Fwd PE 10.38
P/S 1.6
P/FCF 92.27
P/OCF 14.58
P/B 1.91
P/tB 1.91
EV/EBITDA 9.12
EPS(TTM)3.29
EY10.46%
EPS(NY)3.03
Fwd EY9.63%
FCF(TTM)0.34
FCFY1.08%
OCF(TTM)2.16
OCFY6.86%
SpS19.66
BVpS16.51
TBVpS16.51
PEG (NY)N/A
PEG (5Y)0.19
Profitability
Industry RankSector Rank
ROA 7.33%
ROE 9.42%
ROCE 8.92%
ROIC 6.87%
ROICexc 12.91%
ROICexgc 12.91%
OM 9.1%
PM (TTM) 7.91%
GM 13.22%
FCFM 1.73%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score4
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.29
Debt/EBITDA 0.04
Cap/Depr 356.45%
Cap/Sales 9.23%
Interest Coverage 250
Cash Conversion 93.79%
Profit Quality 21.93%
Current Ratio 10.53
Quick Ratio 9.68
Altman-Z 7.51
F-Score4
WACC8.66%
ROIC/WACC0.79
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y51.01%
EPS Q2Q%-38.46%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-9.48%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%7.03%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-22.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-73.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.77%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%